NEWS
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/07/Mishima-et-al-Nature-feature.png
466
634
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-07-13 09:10:422024-01-22 13:35:05Nature: DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition
Alborizina et al 2023
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/07/Alborizina-et-al23.png
681
633
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-07-12 17:59:392023-09-21 10:54:09EMBO Mol Med.: LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma
Helmholtz Munich | ©Claudia Dalke
https://www.dfg-ferroptosis.net/wp-content/uploads/2023/09/DSC_0999-mod-v16062023-for-Nakamura-et-al-Nature-2023.jpg
816
1280
ViewerSPP
https://www.dfg-ferroptosis.net/wp-content/uploads/2022/05/SPP-1-1030x522.jpg
ViewerSPP2023-07-12 09:10:212024-01-22 13:11:41Nature: Phase separation of FSP1 promotes ferroptosis.

